Health
COVID-19: Cambridge vaccine gets £1.9 million to begin clinical trials – BBC Focus Magazine
Scientists at Cambridge say they aim to make a vaccine that will not only protect from SARS-CoV-2, but also other related coronaviruses.
A coronavirus vaccine candidate developed by the University of Cambridge could begin clinical trials in the UK in the autumn.
A £1.9 million funding boost from Innovate UK, the governments innovation agency, has provided support for a collaboration between Cambridge spin-out company DIOSynVax, the University of Cambridge and the University Hospital Southampton NHS Foundation Trust.
The funding of £1.9 million will allow the team to take the vaccine candidate to clinical trial at the University…
-
General21 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General19 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News19 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
Noosa News20 hours agoBack to the Future the Musical’s extraordinary visual effects mean you’ll see the DeLorean fly